Author:
Channa R, ,Sophie R,Khwaja A A,Do D V,Hafiz G,Nguyen Q D,Campochiaro P A
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Klein R, Klein B . Vision disorders in diabetes. In: Group NDD editor, Diabetes in America 2nd ed. National Institutes of Health: Washington, DC, USA, 1995 pp 293–330.
2. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006; 142: 961–969.
3. Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D et al. Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study. Ophthalmology 2009; 116: 2175–2181.
4. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV et al. Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study. Ophthalmology 2010; 117: 2146–2151.
5. The Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibzumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmolgy 2010; 117: 1064–1077.
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献